ATCvet code:QI02AO02
Pharmacotherapeutic group
The vaccine contains purified Cryptosporidium parvum glycoprotein 40 adjuvanted with mineral oil and aluminium hydroxide.
The vaccine is intended to stimulate active immunity of the vaccinated dam in order to provide passive immunity against Cryptosporidium parvum to the progeny.